- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06638320
Hepatit Delta-virusinfektion: tvärsnittsstudie hos patienter med kronisk hepatit B-virusinfektion
The goal of this observational study is to determine the prevalence of hepatitis D virus (HDV) and the distribution of the HDV genotype in patients with chronic hepatitis B infection. It will also identify factors related to hepatitis D virus infection, such as characteristics of the study sample, vaccination history, drug use affecting hepatitis, family factors, environment, and lifestyle.
This study will be conducted at Tam Anh General Hospital, Bach Mai Hospital and Tam Anh TP. Ho Chi Minh General Hospital.
Participants will be interviewed directly through a questionnaire to collect some information related to epidemiological risk factors. A blood sample will also be collected.
Studieöversikt
Status
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Loc Tho Truong, MSc
- Telefonnummer: 1668 +842871026789
- E-post: loctt@tamri.vn
Studieorter
-
-
Northern Vietnam
-
Hà Nội, Northern Vietnam, Vietnam, 100000
- Rekrytering
- Bach Mai General Hospital
-
Kontakt:
- Long Công Nguyen, Associate Professor
- Telefonnummer: +841900888866
- E-post: nguyenconglongbvbm@gmail.com
-
Hà Nội, Northern Vietnam, Vietnam, 100000
- Rekrytering
- Tam Anh General Hospital
-
Kontakt:
- Khanh Truong Vu, MD, PhD
- Telefonnummer: 02471066858
- E-post: khanhvt@tamanhhospital.vn
-
-
Southern Vietnam
-
Ho Chi Minh City, Southern Vietnam, Vietnam, 700000
- Rekrytering
- Tam Anh TP. Ho Chi Minh General Hospital
-
Kontakt:
- Tran Quang Quang, Associate Professor
- Telefonnummer: 0903841479
- E-post: binhtq@hcm.tahospital.vn
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Patients ≥ 16 years old with chronic hepatitis B, with hepatocellular carcinoma and cirrhosis or not, should be examined and treated at the Gastroenterology - Hepatobiliary Center of Bach Mai Hospital, Tam Anh General Hospital and Tam Anh TP. Ho Chi Minh General Hospital.
Beskrivning
Inclusion Criteria:
- Patients ≥ 16 years old undergo testing at the Testing Center of Tam Anh General Hospital or Tam Anh TP. Ho Chi Minh General Hospital, with chronic hepatitis B HBsAg (+) standards for six months or over or HBsAg (+) combined with HBcAb total (+) and HBcAb-immunoglobulin M (-).
- Patients ≥ 16 years old with chronic hepatitis B come to be examined or are inpatients at the Gastroenterology - Hepatobiliary Center of Bach Mai Hospital, diagnosed with hepatocellular carcinoma, and cirrhosis
Exclusion Criteria:
- Patients do not agree to participate in the study or refuse to sign a written informed consent.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: ECOLOGIC_OR_COMMUNITY
- Tidsperspektiv: CROSS_SECTIONAL
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Patienter med kronisk hepatit B-virusinfektion
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Prevalence of hepatitis D virus (HDV) in patients with chronic hepatitis B infection
Tidsram: Day 0 after recruitment
|
The method of estimating prevalence based on the assumption of binary distribution will be applied to the entire study sample and each subgroup. The prevalence rate will be estimated by dividing the number of positive cases by the sample size. The 95% confidence interval of the prevalence will be calculated based on the binary distribution assumption. Prevalence will be estimated for each sex, age, and disease group (chronic hepatitis B, chronic hepatitis B with hepatocellular carcinoma, and cirrhosis). |
Day 0 after recruitment
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Distribution of the HDV genotype in patients with chronic hepatitis B infection
Tidsram: Day 0 after recruitment
|
Testing for differences in genotypic distribution between disease groups will be analyzed using the Chi-squared test. The difference is statistically significant with p < 0.05. |
Day 0 after recruitment
|
|
Factors related to hepatitis D virus infection
Tidsram: Day 0 after recruitment
|
The determination of the association between risk factors and HDV will be analyzed across the total study sample. The multivariate logistic regression method will be applied in determining the variables related to the probability of HDV infection. In this analysis, HDV infection (positive or negative) is the dependent variable; Independent variables include factors that reflect demography, lifestyle, environment, occupation, clinical history (including vaccinations), and history of drug use. There are many independent variables and these variables can be correlated, determining which one affects HDV infection is a major challenge. To solve this problem, we will apply the Bayesian Model Averaging method in the R library. Based on the results of this analysis, a prognostic model of the risk of HDV infection will be established. |
Day 0 after recruitment
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Blodburna infektioner
- Patologiska processer
- Kronisk sjukdom
- Sjukdomsegenskaper
- Infektioner
- Virussjukdomar
- Matsmältningssystemets sjukdomar
- Leversjukdomar
- Hepatit, Viral, Human
- Smittsamma sjukdomar
- DNA-virusinfektioner
- Hepadnaviridae-infektioner
- Hepatit, kronisk
- Hepatit
- Patologiska tillstånd, tecken och symtom
- Hepatit B
- Hepatit B, kronisk
Andra studie-ID-nummer
- TA-0001
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .